About the journal
Biomarkers in Medicine is a journal published by Future Medicine in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Future Medicine
- ISSN
- 1752-0363 · 1752-0371
- Country
- United Kingdom
- Access
- Not open access / not declared
- Official website
- http://www.futuremedicine.com/loi/bmm
Index listings
- MEDLINE · 2010-01-01
- PUBMED · 2008-12-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2308
Last recorded publication year
2026
h-index
72
i10-index
977
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 57%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101312535
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
Show all subjects (50)
- Circular RNAs in diseases
- Adipokines, Inflammation, and Metabolic Diseases
- Adipokines, Inflammation, and Metabolic Diseases
- Circular RNAs in diseases
- Cardiovascular Function and Risk Factors
- Cardiovascular Function and Risk Factors
- RNA modifications and cancer
- RNA modifications and cancer
- Sepsis Diagnosis and Treatment
- Sepsis Diagnosis and Treatment
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Heart Failure Treatment and Management
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Acute Myocardial Infarction Research
- Alzheimer's disease research and treatments
- Alzheimer's disease research and treatments
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Acute Kidney Injury Research
- Acute Kidney Injury Research
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Imaging and Diagnostics
- Cardiac Imaging and Diagnostics
- S100 Proteins and Annexins
- Metabolomics and Mass Spectrometry Studies
- Metabolomics and Mass Spectrometry Studies
- S100 Proteins and Annexins
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Venous Thromboembolism Diagnosis and Management
- Cancer, Hypoxia, and Metabolism
- Venous Thromboembolism Diagnosis and Management
- Cancer, Hypoxia, and Metabolism
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ